Pillai Arun Kumar
Insider CIK 1717437 · ONS Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OTLK Outlook Therapeutics, Inc. | J Other | 2022-02-01 | 2022-02-01 | 2,500,000 | $1.25 | $3.13M | 22,982,529 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise deriv | 2020-03-23 | 2020-03-23 | 68,112 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise | 2020-03-23 | 2020-03-23 | 29,358,621 | — | $0 | 50,965,058 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | D To issuer deriv | 2020-03-19 | 2020-03-23 | 68,112 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-03-19 | 2020-03-23 | 68,112 | — | $0 | 68,112 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise deriv | 2020-01-29 | 2020-01-29 | 2,093,750 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise deriv | 2020-01-29 | 2020-01-29 | 1,282,051 | $1.00 | $1.28M | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise deriv | 2020-01-29 | 2020-01-29 | 1,282,051 | $1.00 | $1.28M | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise | 2020-01-29 | 2020-01-29 | 4,657,852 | $0.23 | $1.07M | 21,606,437 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-01-27 | 2020-01-29 | 1,282,051 | $1.00 | $1.28M | 1,282,051 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | D To issuer deriv | 2020-01-27 | 2020-01-29 | 1,282,051 | $1.00 | $1.28M | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-01-27 | 2020-01-29 | 1,282,051 | $1.00 | $1.28M | 1,282,051 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | D To issuer deriv | 2020-01-27 | 2020-01-29 | 1,282,051 | $1.00 | $1.28M | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-01-27 | 2020-01-29 | 2,093,750 | — | $0 | 2,039,750 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | D To issuer deriv | 2020-01-27 | 2020-01-29 | 2,093,750 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other deriv | 2019-12-31 | 2019-12-31 | 1,661 | — | $0 | 68,112 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise deriv | 2019-12-23 | 2019-12-30 | 3,636,364 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise | 2019-12-23 | 2019-12-30 | 2,909,091 | $0.23 | $669.1K | 16,948,585 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other deriv | 2019-09-30 | 2019-09-30 | 1,620 | — | $0 | 66,451 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other deriv | 2019-06-30 | 2019-07-01 | 1,581 | — | $0 | 64,831 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise deriv | 2019-06-17 | 2019-06-19 | 3,636,364 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise | 2019-06-17 | 2019-06-19 | 2,181,818 | — | $0 | 14,039,494 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2019-04-12 | 2019-04-16 | 3,636,364 | — | $0 | 3,636,364 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2019-04-12 | 2019-04-16 | 3,636,364 | — | $0 | 3,636,364 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award | 2019-04-12 | 2019-04-16 | 3,636,364 | $2.75 | $10.00M | 11,857,676 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other deriv | 2019-03-31 | 2019-04-02 | 1,542 | — | $0 | 63,250 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award | 2019-02-01 | 2019-02-05 | 4,288,624 | $0.93 | $3.99M | 65,770,503 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award | 2019-01-02 | 2019-01-03 | 4,288,624 | $0.93 | $3.99M | 61,481,879 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other deriv | 2018-12-31 | 2018-12-31 | 1,505 | — | $0 | 61,708 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award | 2018-12-03 | 2018-12-06 | 4,288,624 | $0.93 | $3.99M | 57,193,255 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award | 2018-11-07 | 2018-11-09 | 8,577,248 | $0.93 | $7.98M | 52,904,631 | SEC↗ |
| ONS Oncobiologics, Inc. | J Other deriv | 2018-09-30 | 2018-10-02 | 1,648 | — | $0 | 60,383 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other deriv | 2018-09-30 | 2018-12-31 | 1,468 | — | $0 | 60,203 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-07-18 | 2018-07-20 | 58,735 | — | $0 | 58,735 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-07-18 | 2018-07-20 | 6,526 | — | $0 | 58,735 | SEC↗ |
| ONS Oncobiologics, Inc. | D To issuer deriv | 2018-07-18 | 2018-07-20 | 58,735 | — | $0 | 0 | SEC↗ |
| ONS Oncobiologics, Inc. | C Conversion deriv | 2018-06-20 | 2018-06-25 | 208,836 | — | $0 | 52,209 | SEC↗ |
| ONS Oncobiologics, Inc. | C Conversion | 2018-06-20 | 2018-06-25 | 31,572,617 | — | $0 | 44,327,383 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-06-08 | 2018-06-25 | 10,256,410 | $0.13 | $1.33M | 20,512,820 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award | 2018-06-08 | 2018-06-25 | 6,377,383 | $0.98 | $6.25M | 12,754,766 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-05-14 | 2018-06-25 | 10,256,410 | $0.13 | $1.33M | 10,256,410 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award | 2018-05-14 | 2018-06-25 | 6,377,383 | $0.98 | $6.25M | 6,377,383 | SEC↗ |
| ONS Oncobiologics, Inc. | J Other deriv | 2018-03-31 | 2018-06-25 | 6,367 | — | $0 | 261,045 | SEC↗ |
| ONS Oncobiologics, Inc. | J Other deriv | 2017-12-31 | 2018-06-25 | 4,678 | — | $0 | 254,678 | SEC↗ |
| ONS Oncobiologics, Inc. | P Buy deriv | 2017-10-31 | 2017-11-01 | 217,372 | $100.00 | $21.74M | 250,000 | SEC↗ |
| ONS Oncobiologics, Inc. | P Buy deriv | 2017-10-31 | 2017-11-01 | 16,750,000 | — | $0 | 16,750,000 | SEC↗ |